CLINICAL STUDIES
Predictive factors of adherence to an association of glucosamine sulfate, copper, and ginger extracts in patients with symptomatic osteoarthritis: a prospective open-label French noninterventional study (the PREDOA study)
New Publication about Cuivramine® with the PREDOA Study conducted on more than 2000 patients Guidelines recommend symptomatic slow-acting drugs for OA (SYSADOA) to reduce pain and avoid the use of NSAIDs. However, the main issue with slow-acting treatments is the Read more…
